🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Egypt / NCT06984965
Recruiting Observational

Role of EEG in Differentiation Between Ischemic and Hemorrhagic Stroke

NCT06984965 · tracked via the Priya Life Science Egypt tracker
Phase
Observational
Started
2025-06
Last updated
2025-05-22

Condition(s) studied

Acute Ischemic StrokeAcute Haemorrhagic Stroke

Study summary

Searching electrical activity registered by EEG in acute ischemic and hemorrhagic stroke and comparing these parameters to the poststroke recovery patterns to investigate the role of EEG as a differentiation tool and as a predictor of post-stroke recovery.

Eligibility

Sex
ALL
Min age
18 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria: * Age above 18 and below 80 years. * Acute Ischemic stroke: ischemic arteria cerebri media infarct confirmed by MRI. * Acute Hemorrhagic stroke: spontaneous intraparenchymal bleeding confirmed by CT. * Stroke onset \<72 hours before expected time of performing EEG. * First-ever ischemic stroke. * Measurable deficit on the National Institute of Health Stroke Scale (NIHSS). * Able to give and sign informed consent. Exclusion Criteria: * Transient Ischemic Attacks (TIAs). * Greater than 72 hours past the initial insult. * Patients with subarachnoid haemorrhage, traumatic haemorrhage (epidural/subdural bleeding), cerebral venous sinus thrombosis, indication for urgent neurosurgical intervention. * History of other central nervous system diseases. * Any signs unfit for MRI/EEG scan. * Injury or active infection of electrode cap placement area. * Claustrophobia; recognition disorder. * Known skull defect or head trauma. * Previous neurological procedure (metallic implant, brain pace, cranial operation history). * Significant physical impairment that would restrict the ability to use the portable EEG devices. * Presence of malignancy or systemic rheumatic disease * Non-stroke disease or lesion affecting the sensorimotor system. * Alcohol or drug addiction. * Presence of pump/shunt. * Presence of Malignancy. * Presence of severe cognitive impairment. * History of epilepsy or taking medication due to epilepsy.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Neurology Department, Faculty of Medicine, Assiut University Asyut Asyut Governorate Recruiting

More Assiut University trials in Egypt

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06984965 on ClinicalTrials.gov ↗ ← All trials in Egypt